Latest News about REGN
Recent news which mentions REGN
Regeneron's Lynozyfic Gains Accelerated FDA Approval For Heavily Pre-Treated Multiple Myeloma
Today 9:37 EDT
From Benzinga
Here's How Much $100 Invested In Regeneron Pharmaceuticals 20 Years Ago Would Be Worth Today
July 01, 2025
From Benzinga
From Benzinga
$100 Invested In Regeneron Pharmaceuticals 20 Years Ago Would Be Worth This Much Today
June 20, 2025
From Benzinga
From Benzinga
From Benzinga
From Motley Fool
From Motley Fool
Tickers
REGN
From Motley Fool
Novo Nordisk, Deep Apple Launch Drug Discovery Alliance For Weight Loss Oral Therapies
June 11, 2025
From Benzinga
From Benzinga
From Benzinga
Here's How Much You Would Have Made Owning Regeneron Pharmaceuticals Stock In The Last 15 Years
June 03, 2025
From Benzinga
From Benzinga
From Benzinga
From Motley Fool
From Benzinga
Benzinga Bulls And Bears: Nvidia, Palantir, Marvell Technology — And Markets Rallied In May
May 31, 2025
From Benzinga
From TalkMarkets
Elastic, Gap, Regeneron Pharmaceuticals And Other Big Stocks Moving Lower In Friday's Pre-Market Session
May 30, 2025
From Benzinga
From Benzinga
From Benzinga
The Company Buying 23andMe Is a Pharmaceutical Giant. Here's How Investors Can Benefit From the Move.
May 29, 2025
Tickers
REGN
From Motley Fool
From Benzinga
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.
Business Insurance is a singular, authoritative news and information source for executives focused upon risk management, risk transfer and risk financing.
Never miss important news. Subscribe to our newsletter.
Register for free
Information
Copyright 2024. BUSINESS INSURANCE HOLDINGS
